Byfavo - (20 mg/vial ; Powder for Injection)

Generic Name	Remimazolam Besylate	Innovator	Acacia
Dosage	20 mg/vial ; Powder for Injection	Branded US Sales	Less Than $1000 mn
Probable FTF	Less Than 5	Known Para IV Filers	Less Than 5
Other ANDA developers	Less Than 5	Tentative Approvals	None
Final Approvals	None	Generic Launches	None
Indication	BYFAVO(remimazolam) for injection is a benzodiazepine indicated for the induction and maintenance of procedural sedation in adults undergoing procedures lasting 30 minutes or less.
Complexities	Yes

Executive Summary

Patent Status

Launch Timelines and Competition

Company	FTF Status / 180 days exclusivity	30-Months stay	Current Litigation Status	Current Approval Status	Likelihood of launch
********* ******	*** / *********	*** **, ****	*******	****	*** ****** *** ****

Chronology Of Events